Umlando

« Emuva ku-Pipeline

Esikufezile:

I-Sorrento ibe nohambo olude ukusuka ekuqaleni okuthobekile kuya ku-biopharma ehlukahlukene ithola futhi ithuthukisa imithi eshintsha ukuphila.

2009

Wasekelwa

2013

Impahla ezuziwe ye-Resiniferatoxin (RTX) ngokutholwa kwe-Sherrington Pharmaceuticals Inc.
Ubuchwepheshe be-Acquired Antibody Conjugation (ADC) ngokutholwa kwe-Concortis Biosystems Corp.

2014

I-PD-L1 enelayisensi engaphandle yemakethe ye-Greater China ku-Lee's Pharm

2016

Kwakhiwe i-ImmuneOncia JV ne-Yuhan Pharmaceuticals
Kutholwe i-ZTlido® Ngesabelo esikhulu se-Scilex Pharmaceuticals
I-Acquired Bioserv Corporation yemisebenzi yokukhiqiza ye-cGMP
Kwakhiwe i-Levena Suzhou Biopharma Co. LTD yezinsiza zokuhlanganisa i-Antibody Drug Conjugation (ADC).

2017

Inkundla ye-Oncolytic Virus ezuziwe ngokutholwa kwe-Virttu Biologics Limited
Yakha ubulula ne-Celgene kanye ne-United Therapeutics

2018

Kutholwe uSofusa® I-Lymphatic Delivery System evela ku-Kimberly-Clark

2019

Kutholwe I-Semnur Pharmaceuticals
Kwakhiwe i-Scilex Holding ukuze kuhlanganiswe ukuhlanganiswa kwe-Scilex Pharma kanye ne-Semnur Pharma

2020

I-Abivertinib enelayisensi ekhethekile evela kwa-ACEA Therapeutics yazo zonke izinkomba emhlabeni jikelele, ngaphandle kwe-China
Inkundla yokuxilonga i-HP-LAMP enelayisensi ekhethekile evela e-Columbia University ukuze kutholwe ama-coronavirus kanye namagciwane omkhuhlane
Kutholwe I-SmartPharm Therapeutics

2021

Kutholwe i-ACEA Therapeutics

2022

Kutholwe i-Virexealth